Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Human RSPO3 Antibody (Iv0181)

Catalog #:   VHJ51101 Specific References (14) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, FCM, Neutralization
Accession: Q9BXY4
Overview

Catalog No.

VHJ51101

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

RSPO3, hPWTSR, hRspo3, PWTSR, R-spondin-3, Thrombospondin type-1 domain-containing protein 2, Protein with TSP type-1 repeat, Roof plate-specific spondin-3, THSD2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9BXY4

Applications

ELISA, FCM, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0181

Data Image
  • Flow-cytometry
    Flow-cytometry using anti-human RSPO3 antibody.RSPO3 Transfected CHO cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human RSPO3 antibody monoclonal antibody (Catalog # VHJ51101 ,Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody (Catalog # PHB96441) and cells analysed on a NovoCyte Flow Cytometer.
References

Coactivation of Tie2 and Wnt signaling using an antibody-R-spondin fusion potentiates therapeutic angiogenesis and vessel stabilization in hindlimb ischemia., PMID:39607038

RSPO3 regulates the radioresistance of Non-Small cell lung cancer cells via NLRP3 Inflammasome-Mediated pyroptosis., PMID:39245068

R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling., PMID:37406727

R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer., PMID:36106661

Not All Wnt Activation Is Equal: Ligand-Dependent versus Ligand-Independent Wnt Activation in Colorectal Cancer., PMID:33202731

Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia., PMID:32559496

R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling., PMID:32432544

Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs., PMID:32160239

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis., PMID:31348891

Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)., PMID:29048660

Molecular genetics and targeted therapy of WNT-related human diseases (Review)., PMID:28731148

Preclinical development of a humanized neutralizing antibody targeting HGF., PMID:28336956

RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes., PMID:26735887

Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function., PMID:26700806

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Human RSPO3 Antibody (Iv0181) [VHJ51101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only